MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Systemic Lupus Erythematosus presenting as Chorea

H. Chovatiya (Surat, India)

Meeting: 2025 International Congress

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis

Category: Choreas (Non-Huntington's Disease)

Objective: To study the clinical course, imaging, diagnosis and management of acute onset of generalized chorea with suspected Systemic lupus Erythematosus (SLE).

Background: Neuropsychiatric symptoms of SLE (NPSLE) comprise of 19 syndromes, including movement disorders1.  Chorea, a hyperkinetic movement disorder characterised by involuntary, dance-like, and unpredictable movements, is rare in SLE, with a cumulative incidence of 0.6%.2

Method: A 17 year old boy, first-born child of healthy and non-consanguineous parents, presented with generalized chorea, difficulty in speaking, writing and walking for last 1 months, without history of dystonia, tremor, feeding difficulty and psychiatric or cognitive impairment. There is no relevant past or family history, including neuroleptic ingestion. Further, his mother informed of intermittent fever, dry cough, back pain, joint pain and leg pain with pedal oedema since last 3 years, with multiple admissions and symptomatic management.

On physical examination, he was conscious, oriented and following commands, with normal cranial nerve, motor, sensory and cerebellar examination. He has generalized chorea involving all four limbs, face and tongue.

Results: Renal and Liver function tests were normal. ASO Titer [47 IU/ml (normal<200IU/ml)] was normal. Significant derangements were Hypochromic Microcytic Anemia [Hb 9.5g/dl, MCV 73.9fl, MCH 23.2pg] with proteinuria (176 mg/dl) and positive APLA, Direct Coomb’s Test and ANA. Further evaluation showed positive dsDNA antibody (187.85 IU/ml), low C3 level [51 mg/dl] (Normal 88-165)  and low C4 Level [<8 mg/dl] (Normal 14-44)]. 2D Echo and MRI Brain were normal.

He was started on immunosuppressive therapy – methylprednisolone 1g/day for three days, followed by prednisone 1mg/kg/day and mycophenolate mofetil, up to a dose of 2g/day and Tab. Tetrabenazine 75mg/day and Tab. Risperidone 2mg/day without any response. Hence, Inj. Rituximab 1gm was administered with favourable response with completely resolution of chorea.

Conclusion: Our case highlights the crucial importance of a well-conducted interview and clinical observation, and the richness of a thorough differential diagnosis, underlining the importance of maintaining a high index of suspicion. This case illustrates the relevance of SLE in the differential diagnosis of acute-onset movement disorders in young patients.

References: 1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42:4-599.
2. Bertsias GK, Boumpas DT: Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol. 2010, 6:358-67.

To cite this abstract in AMA style:

H. Chovatiya. Systemic Lupus Erythematosus presenting as Chorea [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/systemic-lupus-erythematosus-presenting-as-chorea/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/systemic-lupus-erythematosus-presenting-as-chorea/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley